Progress in the understanding of molecular mechanisms that underlie tumor development and progression has generated an increasing number of novel therapeutic options for cancer patients. These options intensify the trend towards individualized cancer therapy.
Medical education is challenged to take these developments into account. We present a pilot project conducted at our institutions for this purpose.